These results implicate HLA-C*04:01 allele in COVID-19 severity with a biological consequence affecting HLA class I qualitative and quantitative properties, and serving as a genetic determinant for the SARS-CoV-2 peptide presentation quantitative trait (QT) beyond its effect on the HLA-C locus. The gene discussed is HLA-C; the disease is COVID-19.